These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 18800146)

  • 21. Arsenic disulfide synergizes with the phosphoinositide 3-kinase inhibitor PI-103 to eradicate acute myeloid leukemia stem cells by inducing differentiation.
    Hong Z; Xiao M; Yang Y; Han Z; Cao Y; Li C; Wu Y; Gong Q; Zhou X; Xu D; Meng L; Ma D; Zhou J
    Carcinogenesis; 2011 Oct; 32(10):1550-8. PubMed ID: 21803735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leukemia stem cells in drug resistance and metastasis.
    Deng CH; Zhang QP
    Chin Med J (Engl); 2010 Apr; 123(7):954-60. PubMed ID: 20497694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting the cancer initiating cell: the ultimate target for cancer therapy.
    McCubrey JA; Steelman LS; Abrams SL; Misaghian N; Chappell WH; Basecke J; Nicoletti F; Libra M; Ligresti G; Stivala F; Maksimovic-Ivanic D; Mijatovic S; Montalto G; Cervello M; Laidler P; Bonati A; Evangelisti C; Cocco L; Martelli AM
    Curr Pharm Des; 2012; 18(13):1784-95. PubMed ID: 22394167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The leukemic stem cell.
    Jordan CT
    Best Pract Res Clin Haematol; 2007 Mar; 20(1):13-8. PubMed ID: 17336250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukemic stem cells: a review.
    O'Brien JA; Rizzieri DA
    Cancer Invest; 2013 May; 31(4):215-20. PubMed ID: 23473080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting of CD44 eradicates human acute myeloid leukemic stem cells.
    Jin L; Hope KJ; Zhai Q; Smadja-Joffe F; Dick JE
    Nat Med; 2006 Oct; 12(10):1167-74. PubMed ID: 16998484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can inhibition of the SDF-1/CXCR4 axis eradicate acute leukemia?
    Tavor S; Petit I
    Semin Cancer Biol; 2010 Jun; 20(3):178-85. PubMed ID: 20637871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Recent progress in leukemic stem cell research for childhood leukemia].
    Eguchi M; Eguchi-Ishimae M; Ishii E
    Rinsho Ketsueki; 2015 Oct; 56(10):1871-81. PubMed ID: 26458424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leukemia stem cells.
    Luo L; Han ZC
    Int J Hematol; 2006 Aug; 84(2):123-7. PubMed ID: 16926133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective and effective targeting of chronic myeloid leukemia stem cells by topoisomerase II inhibitor etoposide in combination with imatinib mesylate in vitro.
    Liu MY; Wang WZ; Liao FF; Wu QQ; Lin XH; Chen YH; Cheng L; Jin XB; Zhu JY
    Cell Biol Int; 2017 Jan; 41(1):16-23. PubMed ID: 27677634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression.
    Kikushige Y; Miyamoto T; Yuda J; Jabbarzadeh-Tabrizi S; Shima T; Takayanagi S; Niiro H; Yurino A; Miyawaki K; Takenaka K; Iwasaki H; Akashi K
    Cell Stem Cell; 2015 Sep; 17(3):341-52. PubMed ID: 26279267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flow cytometric quantification and immunophenotyping of leukemic stem cells in acute myeloid leukemia.
    Hwang K; Park CJ; Jang S; Chi HS; Kim DY; Lee JH; Lee JH; Lee KH; Im HJ; Seo JJ
    Ann Hematol; 2012 Oct; 91(10):1541-6. PubMed ID: 22669506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leukaemic stem cells: drug resistance, metastasis and therapeutic implications.
    Wong RS; Cheong SK
    Malays J Pathol; 2012 Dec; 34(2):77-88. PubMed ID: 23424769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-Cadherin and Tie2 positive CD34⁺CD38⁻CD123⁺ leukemic stem cell populations can develop acute myeloid leukemia more effectively in NOD/SCID mice.
    Qiu S; Jia Y; Xing H; Yu T; Yu J; Yu P; Tang K; Tian Z; Wang H; Mi Y; Rao Q; Wang M; Wang J
    Leuk Res; 2014 May; 38(5):632-7. PubMed ID: 24703771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enrichment of N-Cadherin and Tie2-bearing CD34+/CD38-/CD123+ leukemic stem cells by chemotherapy-resistance.
    Zhi L; Wang M; Rao Q; Yu F; Mi Y; Wang J
    Cancer Lett; 2010 Oct; 296(1):65-73. PubMed ID: 20444543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phytochemical Modulation of Apoptosis and Autophagy: Strategies to Overcome Chemoresistance in Leukemic Stem Cells in the Bone Marrow Microenvironment.
    Owen HC; Appiah S; Hasan N; Ghali L; Elayat G; Bell C
    Int Rev Neurobiol; 2017; 135():249-278. PubMed ID: 28807161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of cantharidins on leukemic stem cells.
    Dorn DC; Kou CA; Png KJ; Moore MA
    Int J Cancer; 2009 May; 124(9):2186-99. PubMed ID: 19123473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel strategies for targeting leukemia stem cells: sounding the death knell for blood cancer.
    Chavez-Gonzalez A; Bakhshinejad B; Pakravan K; Guzman ML; Babashah S
    Cell Oncol (Dordr); 2017 Feb; 40(1):1-20. PubMed ID: 27678246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bmi1 is essential for leukemic reprogramming of myeloid progenitor cells.
    Yuan J; Takeuchi M; Negishi M; Oguro H; Ichikawa H; Iwama A
    Leukemia; 2011 Aug; 25(8):1335-43. PubMed ID: 21527932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene sets identified with oncogene cooperativity analysis regulate in vivo growth and survival of leukemia stem cells.
    Ashton JM; Balys M; Neering SJ; Hassane DC; Cowley G; Root DE; Miller PG; Ebert BL; McMurray HR; Land H; Jordan CT
    Cell Stem Cell; 2012 Sep; 11(3):359-72. PubMed ID: 22863534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.